(VIANEWS) – Invesco Trust for Investment Grade New York Municipals (VTN), WhiteHorse Finance (WHF), Plains Group Holdings, L.P. (PAGP) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Invesco Trust for Investment Grade New York Municipals (VTN)
264.38% Payout Ratio
Invesco Trust for Investment Grade New York Municipals is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited, and INVESCO Senior Secured Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade New York municipal securities which include municipal bonds, municipal notes, municipal commercial paper, and lease obligations. It employs fundamental analysis with bottom-up security selection approach to create its portfolio. The fund was formerly known as Invesco Van Kampen Trust for Investment Grade New York Municipals. Invesco Trust for Investment Grade New York Municipals was formed on March 27, 1992 and is domiciled in the United States.
Earnings Per Share
As for profitability, Invesco Trust for Investment Grade New York Municipals has a trailing twelve months EPS of $0.16.
PE Ratio
Invesco Trust for Investment Grade New York Municipals has a trailing twelve months price to earnings ratio of 67.06. Meaning, the purchaser of the share is investing $67.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.41%.
Yearly Top and Bottom Value
Invesco Trust for Investment Grade New York Municipals’s stock is valued at $10.73 at 08:23 EST, below its 52-week high of $10.76 and way higher than its 52-week low of $8.49.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 14, 2024, the estimated forward annual dividend rate is 0.47 and the estimated forward annual dividend yield is 4.41%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.1%, now sitting on 15.18M for the twelve trailing months.
Volume
Today’s last reported volume for Invesco Trust for Investment Grade New York Municipals is 41520 which is 2.54% below its average volume of 42605.
2. WhiteHorse Finance (WHF)
168.18% Payout Ratio
WhiteHorse Finance, LLC is a business development company.
Earnings Per Share
As for profitability, WhiteHorse Finance has a trailing twelve months EPS of $0.88.
PE Ratio
WhiteHorse Finance has a trailing twelve months price to earnings ratio of 14.19. Meaning, the purchaser of the share is investing $14.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.29%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.2%, now sitting on 103.26M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
WhiteHorse Finance’s EBITDA is 17.31.
Sales Growth
WhiteHorse Finance’s sales growth for the current quarter is negative 4.2%.
Yearly Top and Bottom Value
WhiteHorse Finance’s stock is valued at $12.48 at 08:23 EST, below its 52-week high of $13.69 and way higher than its 52-week low of $11.13.
3. Plains Group Holdings, L.P. (PAGP)
105.94% Payout Ratio
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream energy infrastructure in the United States and Canada. The company operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the transportation of crude oil and NGLs on pipelines, gathering systems, and trucks. It engages in the provision of storage, terminalling, and throughput services primarily for crude oil, NGLs, and natural gas; NGL fractionation and isomerization services; and natural gas and condensate processing services. The company offers logistics services to producers, refiners, and other customers. PAA GP Holdings LLC operates as a general partner of the company. Plains GP Holdings, L.P. was incorporated in 2013 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Plains Group Holdings, L.P. has a trailing twelve months EPS of $1.01.
PE Ratio
Plains Group Holdings, L.P. has a trailing twelve months price to earnings ratio of 17.56. Meaning, the purchaser of the share is investing $17.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.55%.
4. Bank Nova Scotia Halifax (BNS)
68.9% Payout Ratio
The Bank of Nova Scotia provides various banking products and services in Canada, the United States, Mexico, Peru, Chile, Colombia, the Caribbean and Central America, and internationally. It operates through Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets segments. The company offers financial advice and solutions, and banking products, including debit and credit cards, chequing and saving accounts, investments, mortgages, loans, and insurance to individuals; and retail automotive financing solutions. It also provides business banking solutions comprising lending, deposit, cash management, and trade finance solutions to small, medium, and large businesses. In addition, it provides wealth management advice and solutions, including online brokerage, mobile investment, full-service brokerage, trust, private banking, and private investment counsel services; and retail mutual funds, exchange traded funds, liquid alternatives, and institutional funds. The Bank of Nova Scotia was founded in 1832 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Bank Nova Scotia Halifax has a trailing twelve months EPS of $4.56.
PE Ratio
Bank Nova Scotia Halifax has a trailing twelve months price to earnings ratio of 10.95. Meaning, the purchaser of the share is investing $10.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.2%.
5. Devon Energy (DVN)
49.14% Payout Ratio
Devon Energy Corporation, an independent energy company, engages in the exploration, development, and production of oil, natural gas, and natural gas liquids in the United States. It operates in Delaware, Eagle Ford, Anadarko, Williston, and Powder River Basins. The company was founded in 1971 and is headquartered in Oklahoma City, Oklahoma.
Earnings Per Share
As for profitability, Devon Energy has a trailing twelve months EPS of $5.97.
PE Ratio
Devon Energy has a trailing twelve months price to earnings ratio of 8.8. Meaning, the purchaser of the share is investing $8.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.17%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 14, 2024, the estimated forward annual dividend rate is 2.42 and the estimated forward annual dividend yield is 5.24%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Devon Energy’s EBITDA is 2.29.
Yearly Top and Bottom Value
Devon Energy’s stock is valued at $52.54 at 08:23 EST, below its 52-week high of $56.19 and way above its 52-week low of $40.47.
6. Royalty Pharma (RPRX)
31.62% Payout Ratio
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $2.53.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 11.35. Meaning, the purchaser of the share is investing $11.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.34%.
Sales Growth
Royalty Pharma’s sales growth for the current quarter is negative 24.5%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 15, 2024, the estimated forward annual dividend rate is 0.84 and the estimated forward annual dividend yield is 2.77%.
Yearly Top and Bottom Value
Royalty Pharma’s stock is valued at $28.72 at 08:23 EST, way below its 52-week high of $38.19 and way higher than its 52-week low of $25.92.
Volume
Today’s last reported volume for Royalty Pharma is 2511410 which is 4.46% below its average volume of 2628820.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 1% and 1%, respectively.
